BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8055463)

  • 1. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.
    Schutter EM; Kenemans P; Sohn C; Kristen P; Crombach G; Westermann R; Môbus V; Kaufmann M; Caffier H; Schmidt-Rhode P
    Cancer; 1994 Aug; 74(4):1398-406. PubMed ID: 8055463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter study on CA 125 in postmenopausal pelvic masses.
    Maggino T; Gadducci A; D'Addario V; Pecorelli S; Lissoni A; Stella M; Romagnolo C; Federghini M; Zucca S; Trio D
    Gynecol Oncol; 1994 Aug; 54(2):117-23. PubMed ID: 8063233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.
    Schutter EM; Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P; Verheijen RH
    Am J Obstet Gynecol; 2002 Aug; 187(2):385-92. PubMed ID: 12193930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis?
    Valentin L; Ameye L; Jurkovic D; Metzger U; Lécuru F; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2006 Apr; 27(4):438-44. PubMed ID: 16526098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy.
    Padungsutt P; Thirapagawong C; Senapad S; Suphanit I
    Anticancer Res; 2000; 20(2B):1291-5. PubMed ID: 10810437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA 125 in preoperative evaluation of pelvic masses.
    Pyrgiotis E; Salamalekis E; Loghis C; Dima C; Zourlas PA
    Eur J Gynaecol Oncol; 1993; 14(4):279-82. PubMed ID: 8344320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women with a pelvic mass: indicators of malignancy.
    Balbi GC; Musone R; Menditto A; Balbi F; Corcioni C; Calabria G; Maciariello C; Balbi C
    Eur J Gynaecol Oncol; 2001; 22(6):459-62. PubMed ID: 11874083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer.
    Roman LD; Muderspach LI; Stein SM; Laifer-Narin S; Groshen S; Morrow CP
    Obstet Gynecol; 1997 Apr; 89(4):493-500. PubMed ID: 9083301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.
    Valentin L
    Ultrasound Obstet Gynecol; 1999 Oct; 14(4):273-83. PubMed ID: 10586480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of transvaginal ultrasonography and serum CA 125 assay combined with age and hormonal state in the differential diagnosis of pelvic masses.
    Mancuso A; De Vivo A; Triolo O; Irato S
    Eur J Gynaecol Oncol; 2004; 25(2):207-10. PubMed ID: 15032283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA 125 in the diagnosis of pelvic masses.
    Mogensen O; Mogensen B; Jakobsen A
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1187-90. PubMed ID: 2767108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA125 level in women with a pelvic mass.
    Mousavi AS; Borna S; Moeinoddini S
    Int J Gynecol Cancer; 2006; 16 Suppl 1():92-8. PubMed ID: 16515574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
    Chen DX; Schwartz PE; Li XG; Yang Z
    Obstet Gynecol; 1988 Jul; 72(1):23-7. PubMed ID: 3164105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.